INTERNATIONAL ANGIOLOGY

Most read articles over the last three weeks

International Angiology 2024 February;43(1):1-222
Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence
Andrew N. NICOLAIDES *, Jawed FAREED, Alex C. SPYROPOULOS, Rt Horn Lord KAKKAR, Pier L. ANTIGNANI, Efthymios AVGERINOS, Niels BAEKGAARD, Emma BARBER, Ruth L. BUSH, Joseph A. CAPRINI, Daniel L. CLARKE-PEARSON, Patrick VAN DREDEN, Ismail ELALAMI, Grigoris GEROTZIAFAS, Harry GIBBS, Samuel GOLDHABER, Stavros KAKKOS, Elmira LEFKOU, Nicos LABROPOULOS, Renato D. LOPES, Armando MANSILHA, Chryssa PAPAGEORGIOU, Paolo PRANDONI, Eduardo RAMACCIOTTI, Carla ROGNONI, Tomasz URBANEK, Jeanine M. WALENGA

International Angiology 2021 August;40(4):345-57
Update in the management of lipedema
Isabel FORNER-CORDERO *, Angeles FORNER-CORDERO, Győző SZOLNOKY

International Angiology 2018 June;37(3):181-254
Management of chronic venous disorders of the lower limbs. Guidelines According to Scientific Evidence. Part I
Andrew NICOLAIDES *, Stavros KAKKOS, Niels BAEKGAARD, Anthony COMEROTA, Marianne de MAESENEER, Bo EKLOF, Athanasios D. GIANNOUKAS, Marzia LUGLI, Oscar MALETI, Ken MYERS, Olle NELZÉN, Hugo PARTSCH, Michel PERRIN

International Angiology 2010 April;29(2 Suppl 1):49-54
The efficacy of Oral Beraprost Sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans
Matsumoto T., Iwasa K., Kyuragi R., Honma K., Guntani A., Ohmine T., Itoh H., Onohara T., Maehara Y.

International Angiology 2010 April;29(2 Suppl 1):43-8
Prostaglandin receptors EP2 and IP are detectable in atherosclerotic arteries and plaques
Muto A., Nishibe T., Miyauchi Y., Kondo Y., Yamamoto Y., Dardik A.., Shigematsu H.

International Angiology 2018 April;37(2):127-42
Vascular malformations: classification, diagnosis and treatment
Inês M. CARQUEJA, Joel SOUSA *, Armando MANSILHA

International Angiology 2010 April;29(2 Suppl 1):33-42
Genetic polymorphisms of prostacyclin synthase gene and cardiovascular disease
Nakayama T.

International Angiology 2010 April;29(2 Suppl 1):1
Foreword
Shigematsu H.

International Angiology 2010 April;29(2 Suppl 1):55-60
Conservative treatment for patients with intermittent claudication
Sugimoto I., Ohta T., Ishibashi H., Iwata H., Yamada T., Tadakoshi M., Hida N., Orimoto Y.

International Angiology 2010 April;29(2 Suppl 1);61-8
Current status of the medical expenses for the treatment of arteriosclerosis obliterans in Japan
Isaji T., Takayama T., Endo A., Akai A., Kudo M., Kagaya H., Suzuki J., Hashimoto T., Hoshina K., Kimura H., Okamoto H., Shigematsu K., Miyata T.